Media Center

From the news

Recent transaction and litigation

Publications

February / 2012

Israeli tax residency for companies – Tests for determining the place of control and management

The full update (in Hebrew) is available through the PDF icon.

TaxationTaxation
January / 2012

Internet Update: New Web Domain Suffixes

An internet revolution is now underway as ICANN begins to accept applications for new top level domains.

This update gives you a quick summary of the domain name system, lets you know how things are about to change, and offers tips on what you should be aware of and ways to protect your brand and trademarks.

The full update is available through the PDF icon.

Technology and Intellectual PropertyTechnology and Intellectual Property
November / 2011

Representation of Anobit in its acquisition by a multinational corporation

Meitar represented Anobit Israeli semiconductor startup in its acquisition by a multinational corporation.

November / 2011

Advising the underwriters in a $500 million global notes offering by Israel Electric Company

Meitar represented UBS and Barclays Capital as underwriters of the $500 million global notes offering by Israel Electric Company.

November / 2011

Advising the underwriters in a $1.5 billion global notes offering by the State of Israel

Meitar represented UBS, Barclays Capital and Citigroup as underwriters of the $1.5 billion global notes offering by the State of Israel.

November / 2011

Representation of Avaya in its acquisition of Radvision for approximately $230 million in cash

Meitar represented Avaya, a business communications solutions provider, in its acquisition of Radvision, a Tel Aviv-based company developing HD and converged video conferencing solutions, for approximately $230 million in cash. The transaction is expected to be completed during the second quarter of 2012.

November / 2011

Covidien in its acquisition of SuperDimension

Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of SuperDimension, an Israeli company with a cutting-edge technology for minimally-invasive surgical procedures on the lungs, for $300 million in cash, with future earn out payments possible. The transaction is expected to be completed during the second quarter of 2012.